Intellipharmaceutics: Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 - Form 6-K

(marketscreener.com) MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 The following Management Discussion and Analysis should be read in conjunction with the August 31, 2023 condensed unaudited interim consolidated financial...https://www.marketscreener.com/quote/stock/INTELLIPHARMACEUTICS-INTE-1412102/news/Intellipharmaceutics-International-MANAGEMENT-DISCUSSION-AND-ANALYSIS-OF-FINANCIAL-CONDITION-AND-R-45074815/?utm_medium=RSS&utm_content=20231016